biotech / news / / The Manila Times
Professor Belvisi joins from AstraZeneca, where she served as Senior Vice President, Research & Development, Respiratory & Immunology.
Professor Belvisi will establish and lead a new UK research site for Ailux.
KEY POINTS
- Ailux aims for its first internally developed biologics to enter clinical trials by 2027.
- Belvisi led tozorakimab from preclinical research to Phase 3, achieving landmark COPD trial results.
- Ailux is transitioning from AI-native biologics discovery to a fully integrated drug development organization.
COMPANIES
Summarized by Newsio from The Manila Times. How we summarize →